Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.980
-0.120 (-2.35%)
At close: Mar 12, 2026, 4:00 PM EDT
5.03
+0.05 (1.02%)
After-hours: Mar 12, 2026, 4:20 PM EDT

Candel Therapeutics Statistics

Total Valuation

CADL has a market cap or net worth of $364.77 million. The enterprise value is $295.54 million.

Market Cap364.77M
Enterprise Value 295.54M

Important Dates

The next confirmed earnings date is Thursday, March 12, 2026, before market open.

Earnings Date Mar 12, 2026
Ex-Dividend Date n/a

Share Statistics

CADL has 73.25 million shares outstanding. The number of shares has increased by 67.19% in one year.

Current Share Class 73.25M
Shares Outstanding 73.25M
Shares Change (YoY) +67.19%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) 7.98%
Owned by Institutions (%) 34.68%
Float 63.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 5.39
P/TBV Ratio 7.05
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.49, with a Debt / Equity ratio of 0.94.

Current Ratio 13.49
Quick Ratio 13.31
Debt / Equity 0.94
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -22.78

Financial Efficiency

Return on equity (ROE) is -64.58% and return on invested capital (ROIC) is -33.38%.

Return on Equity (ROE) -64.58%
Return on Assets (ROA) -26.00%
Return on Invested Capital (ROIC) -33.38%
Return on Capital Employed (ROCE) -41.54%
Weighted Average Cost of Capital (WACC) -0.22%
Revenue Per Employee n/a
Profits Per Employee -$1.00M
Employee Count38
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.45% in the last 52 weeks. The beta is -0.90, so CADL's price volatility has been lower than the market average.

Beta (5Y) -0.90
52-Week Price Change -37.45%
50-Day Moving Average 5.60
200-Day Moving Average 5.55
Relative Strength Index (RSI) 42.08
Average Volume (20 Days) 1,576,596

Short Selling Information

The latest short interest is 12.99 million, so 17.73% of the outstanding shares have been sold short.

Short Interest 12.99M
Short Previous Month 9.30M
Short % of Shares Out 17.73%
Short % of Float 20.51%
Short Ratio (days to cover) 10.85

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -48.27M
Pretax Income -38.18M
Net Income -38.18M
EBITDA -47.42M
EBIT -48.27M
Earnings Per Share (EPS) -$0.72
Full Income Statement

Balance Sheet

The company has $119.73 million in cash and $49.03 million in debt, with a net cash position of $70.70 million or $0.97 per share.

Cash & Cash Equivalents 119.73M
Total Debt 49.03M
Net Cash 70.70M
Net Cash Per Share $0.97
Equity (Book Value) 51.92M
Book Value Per Share 0.95
Working Capital 112.39M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.31 million and capital expenditures -$587,000, giving a free cash flow of -$38.90 million.

Operating Cash Flow -38.31M
Capital Expenditures -587,000
Free Cash Flow -38.90M
FCF Per Share -$0.53
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CADL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -67.19%
Shareholder Yield -67.19%
Earnings Yield -10.43%
FCF Yield -10.62%

Analyst Forecast

The average price target for CADL is $18.50, which is 271.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target $18.50
Price Target Difference 271.49%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a